$5.89
0.8416.75%
Last update: Jul 16, 8:39 AM
15 minutes delayed
Comments
Loading...
Marker Therapeutics
MRKRNASDAQ
Marker Therapeutics (NASDAQ:MRKR) Stock, Earnings Estimates, EPS, And Revenue
Marker Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-0.430
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Marker Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics | -$0.47 | -$0.43 | — | — | $762.66K | — | — | — | 08/12/2024 | Get Alert |
| MRKR | Marker Therapeutics | -$0.57 | — | -$0.27 | — | $1.23M | — | $1.24M | — | 05/15/2024 | Get Alert |
| MRKR | Marker Therapeutics | -$0.45 | — | -$0.30 | — | $3.31M | — | $1.06M | — | 03/26/2024 | Get Alert |
| MRKR | Marker Therapeutics | -$0.80 | — | -$0.34 | — | $3.95M | — | $257.61K | — | 11/09/2023 | Get Alert |
| MRKR | Marker Therapeutics | -$1.10 | — | -$0.47 | — | $790.51K | — | $762.66K | — | 08/14/2023 | Get Alert |
| MRKR | Marker Therapeutics | -$1.20 | -$0.80 | -$0.57 | 28.75% | $964.32K | — | $4.73M | — | 05/15/2023 | Get Alert |
| MRKR | Marker Therapeutics | -$1.00 | -$1.60 | -$0.45 | 71.88% | $0.00 | — | $3.31M | — | 03/22/2023 | Get Alert |
| MRKR | Marker Therapeutics | -$1.50 | -$1.20 | -$0.80 | 33.33% | $0.00 | $270.00K | $3.95M | 1362.96% | 11/10/2022 | Get Alert |
| MRKR | Marker Therapeutics | -$1.30 | -$1.30 | -$1.10 | 15.38% | $0.00 | $670.00K | $790.51K | 17.99% | 08/11/2022 | Get Alert |
| MRKR | Marker Therapeutics | -$1.60 | — | -$1.20 | — | $0.00 | — | $964.32K | — | 05/13/2022 | Get Alert |
| MRKR | Marker Therapeutics | -$1.80 | -$1.30 | -$1.20 | 7.69% | $0.00 | — | $0.00 | — | 03/17/2022 | Get Alert |
| MRKR | Marker Therapeutics | -$1.60 | -$1.30 | -$1.20 | 7.69% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| MRKR | Marker Therapeutics | -$1.40 | -$1.20 | -$1.30 | -8.33% | $466.79K | — | $0.00 | — | 08/10/2021 | Get Alert |
| MRKR | Marker Therapeutics | -$1.40 | -$1.40 | -$1.60 | -14.29% | $0.00 | — | $0.00 | — | 05/12/2021 | Get Alert |
| MRKR | Marker Therapeutics | -$1.10 | — | -$1.80 | — | $213.19K | — | $0.00 | — | 03/09/2021 | Get Alert |
| MRKR | Marker Therapeutics | -$1.20 | -$1.40 | -$1.60 | -14.29% | $0.00 | — | $0.00 | — | 11/09/2020 | Get Alert |
| MRKR | Marker Therapeutics | -$1.20 | — | -$1.40 | — | — | — | $466.79K | — | 08/10/2020 | Get Alert |
| MRKR | Marker Therapeutics | — | -$1.10 | -$1.40 | -27.27% | — | — | $0.00 | — | 05/11/2020 | Get Alert |
| MRKR | Marker Therapeutics | — | — | -$1.10 | — | — | — | $213.19K | — | 03/12/2020 | Get Alert |
| MRKR | Marker Therapeutics | — | -$1.30 | -$1.20 | 7.69% | — | — | $0.00 | — | 11/12/2019 | Get Alert |
Marker Therapeutics (MRKR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2023 | 2023-05-15 | $-0.57 | $-0.80 | 28.7 % |
| Dec 2022 | 2023-03-22 | $-0.45 | $-1.60 | 71.9 % |
| Sep 2022 | 2022-11-10 | $-0.80 | $-1.20 | 33.3 % |
| Jun 2022 | 2022-08-11 | $-1.10 | $-1.30 | 15.4 % |
Marker Therapeutics (MRKR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2022 | 2022-11-10 | $3.95M | $270.00K | 1363.0 % |
| Jun 2022 | 2022-08-11 | $790.51K | $670.00K | 18.0 % |
FAQ
When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?
Marker Therapeutics (MRKR) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
What were the latest earnings per share (EPS) for Marker Therapeutics (NASDAQ:MRKR)?
The Actual EPS was $-0.27, which missed the estimate of $0.00.
What were Marker Therapeutics’s (NASDAQ:MRKR) revenues?
The Actual Revenue was $1.2M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.